These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 2478428)
1. Adjuvant chemotherapy after radical hysterectomy for cervical carcinoma. Lai CH; Lin TS; Soong YK; Chen HF Gynecol Oncol; 1989 Nov; 35(2):193-8. PubMed ID: 2478428 [TBL] [Abstract][Full Text] [Related]
2. Ten-year survival of patients with locally advanced, stage ib-iib cervical cancer after neoadjuvant chemotherapy and radical hysterectomy. Hwang YY; Moon H; Cho SH; Kim KT; Moon YJ; Kim SR; Kim DS Gynecol Oncol; 2001 Jul; 82(1):88-93. PubMed ID: 11426967 [TBL] [Abstract][Full Text] [Related]
3. Adjuvant chemotherapy in "high risk" patients after Wertheim hysterectomy--10-year survivals. Sivanesaratnam V Ann Acad Med Singap; 1998 Sep; 27(5):622-6. PubMed ID: 9919328 [TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant chemotherapy with vincristine and cisplatin followed by radical hysterectomy and pelvic lymphadenectomy for FIGO stage IB bulky cervical cancer: a Gynecologic Oncology Group pilot study. Eddy GL; Manetta A; Alvarez RD; Williams L; Creasman WT Gynecol Oncol; 1995 Jun; 57(3):412-6. PubMed ID: 7774847 [TBL] [Abstract][Full Text] [Related]
5. Prognostic factors in surgically treated small cell cervical carcinoma followed by adjuvant chemotherapy. Chang TC; Lai CH; Tseng CJ; Hsueh S; Huang KG; Chou HH Cancer; 1998 Aug; 83(4):712-8. PubMed ID: 9708935 [TBL] [Abstract][Full Text] [Related]
6. Adjuvant cytotoxic chemotherapy following Wertheim radical hysterectomy for cervical cancer. Sivanesaratnam V; Sen DK; Jayalakshmi P Aust N Z J Obstet Gynaecol; 1987 Aug; 27(3):231-3. PubMed ID: 2449159 [TBL] [Abstract][Full Text] [Related]
7. Treatment results of adjuvant chemotherapy after radical hysterectomy for intermediate- and high-risk stage IB-IIA cervical cancer. Takeshima N; Umayahara K; Fujiwara K; Hirai Y; Takizawa K; Hasumi K Gynecol Oncol; 2006 Nov; 103(2):618-22. PubMed ID: 16777200 [TBL] [Abstract][Full Text] [Related]
8. Type II radical hysterectomy and adjuvant therapy for pelvic lymph node metastasis with stage IB-IIB cervical carcinoma: a retrospective study of 288 patients. Zheng M; Huang L; Liu JH; Xiong Y; Li JD; Huang X; He L; Ren YF; Wang HY J Surg Oncol; 2011 Oct; 104(5):480-5. PubMed ID: 21538358 [TBL] [Abstract][Full Text] [Related]
9. Combination chemotherapy followed by surgery or radiotherapy in patients with locally advanced cervical cancer. Kirsten F; Atkinson KH; Coppleson JV; Elliott PM; Green D; Houghton R; Murray JC; Russell P; Solomon HJ; Friedlander M Br J Obstet Gynaecol; 1987 Jun; 94(6):583-8. PubMed ID: 2441736 [TBL] [Abstract][Full Text] [Related]
10. A pilot study of adjuvant therapy in patients with cervical cancer at high risk of recurrence after radical hysterectomy and pelvic lymphadenectomy. Wertheim MS; Hakes TB; Daghestani AN; Nori D; Smith DH; Lewis JL J Clin Oncol; 1985 Jul; 3(7):912-6. PubMed ID: 2410573 [TBL] [Abstract][Full Text] [Related]
11. Prognostic factors in patients with bulky stage IB or IIA cervical carcinoma undergoing neoadjuvant chemotherapy and radical hysterectomy. Lai CH; Hsueh S; Chang TC; Tseng CJ; Huang KG; Chou HH; Chen SM; Chang MF; Shum HC Gynecol Oncol; 1997 Mar; 64(3):456-62. PubMed ID: 9062150 [TBL] [Abstract][Full Text] [Related]
12. The long-term efficacy of neoadjuvant chemotherapy followed by radical hysterectomy compared with radical surgery alone or concurrent chemoradiotherapy on locally advanced-stage cervical cancer. Yin M; Zhao F; Lou G; Zhang H; Sun M; Li C; Hou Y; Li X; Meng F; Chen X Int J Gynecol Cancer; 2011 Jan; 21(1):92-9. PubMed ID: 21330834 [TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant chemotherapy and radical surgery in locally advanced cervical carcinoma: a pilot study. Benedetti Panici P; Scambia G; Greggi S; Di Roberto P; Baiocchi G; Mancuso S Obstet Gynecol; 1988 Mar; 71(3 Pt 1):344-8. PubMed ID: 2450323 [TBL] [Abstract][Full Text] [Related]
14. Weekly cisplatin therapy compared with triweekly combination chemotherapy as concurrent adjuvant chemoradiation therapy after radical hysterectomy for cervical cancer. Lee HN; Lee KH; Lee DW; Lee YS; Park EK; Park JS Int J Gynecol Cancer; 2011 Jan; 21(1):128-36. PubMed ID: 21330837 [TBL] [Abstract][Full Text] [Related]
15. Experience with bleomycin, ifosfamide, and cisplatin in primary and recurrent cervical cancer. Buxton EJ Semin Oncol; 1992 Apr; 19(2 Suppl 5):9-17; discussion 17-8. PubMed ID: 1384148 [TBL] [Abstract][Full Text] [Related]
16. [Adjunctive chemotherapy after radical hysterectomy for cervical carcinoma--preliminary report]. Lai CH; Lin TS; Chen HF Changgeng Yi Xue Za Zhi; 1987 Dec; 10(4):307-13. PubMed ID: 2458174 [No Abstract] [Full Text] [Related]
17. Two-year survival: preoperative adjuvant chemotherapy in the treatment of cervical cancer stages Ib and II with bulky tumor. Kim DS; Moon H; Kim KT; Hwang YY; Cho SH; Kim SR Gynecol Oncol; 1989 May; 33(2):225-30. PubMed ID: 2467848 [TBL] [Abstract][Full Text] [Related]
18. [Adjuvant chemotherapy in radical surgery of cervix cancer]. Lahousen M; Haas H; Pickel H Gynakol Rundsch; 1989; 29 Suppl 2():372-4. PubMed ID: 2482234 [No Abstract] [Full Text] [Related]
19. The integration of chemotherapy into the management of locally advanced cervical cancer: a pilot study. Friedlander ML; Atkinson K; Coppleson JV; Elliot P; Green D; Houghton R; Solomon HJ; Russell P; Tattersall MH Gynecol Oncol; 1984 Sep; 19(1):1-7. PubMed ID: 6205943 [TBL] [Abstract][Full Text] [Related]
20. Prognostic factors and impacts of adjuvant therapy in early-stage cervical carcinoma with pelvic node metastases. Lai CH; Chang HC; Chang TC; Hsueh S; Tang SG Gynecol Oncol; 1993 Dec; 51(3):390-6. PubMed ID: 7509304 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]